Labetalol
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Cardiac & Hypertension treatment.
🧴 Clinical Application
Take orally with a glass of water, once or twice daily with or immediately following meals. Swallow extended-release tablets whole; do not crush or chew. Never stop abruptly; taper slowly over 10-14 days.
⚠️ Side Effects
Common: Bradycardia (slow heart rate), fatigue, dizziness, cold extremities, hypotension, erectile dysfunction, vivid dreams. Rare/Severe: Boxed warning: Abrupt cessation can precipitate severe exacerbation of angina, ventricular arrhythmias, or acute myocardial infarction; heart block, cardiogenic shock, and severe bronchospasm in asthmatics.
🛡️ Safety Warnings
Black box warning: Never stop abruptly; sudden discontinuation can precipitate life-threatening rebound tachycardia, severe angina, or fatal myocardial infarction. Contraindicated in sinus bradycardia (< 50 bpm), second- or third-degree AV block, cardiogenic shock, and decompensated heart failure. Caution in bronchial asthma/COPD and diabetes (masks hypoglycemic tachycardia).
Jan Aushadhi Products containing Labetalol
Found 3 generic formulation(s) containing this active ingredient.
Labetalol Hydrochloride Tablets 100mg
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Labetalol Injection 5 mg per ml
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Labetalol 200mg Tablets
Beta-adrenergic receptor antagonist (cardioselective beta-1 blocker, non-selective beta blocker, or third-generation vasodilating beta-blocker with alpha-blockade or nitric oxide release) on the WHO Model List of Essential Medicines. It competitively blocks adrenergic stimulation, reducing heart rate, myocardial contractility, cardiac output, and renin release. Indicated for hypertension, stable angina pectoris, heart failure, cardiac arrhythmias, and post-myocardial infarction secondary prevention.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Labetalol.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Labetalol Hydrochloride Tablets 100mg | 10's | ₹42.19 | LABEBET, LOBET, LABLOL, LABECOR, LABETAMAC | ₹152.29 | 72% Save |
| Labetalol Injection 5 mg per ml | 4 ml Ampoule | ₹55.31 | GravIDOL, ACURELAB | ₹264.13 | 79% Save |
| Labetalol 200mg Tablets | 10's | ₹56.25 | LABEBET | ₹10.97 | N/A |
Frequently Asked Questions (FAQ)
Get answers to common queries about Labetalol generics.